Warfarin was associated with more risk than apixaban (Eliquis; 55.38 vs 21.42 per 1,000 person-years, HR 2.60, 95% CI ...
According to data from amfAR, the Foundation for AIDS Research, about 1.3 million people are on HIV/AIDS treatment in Kenya, ...
The U.S. government's foreign aid freeze has upended the supply chain for medical products crucial for fighting diseases ...
A common CV risk factor calculator for patients with HIV underestimates risk for Black patients and women, while risk for ...
A revolutionary advancement in HIV prevention technology stands at a critical crossroads as recent policy decisions threaten ...
Pepfar-funded HIV organisations in South Africa, who receive their funds through the United States Agency for International ...
The Trump administration's global aid freeze is threatening the lives of HIV-positive orphans at Nyumbani Children's Home in ...
MadameNoire breaks down three common myths about HIV that persist today. Together, let's uncover the truth behind the stigma.
David Furnish’s leadership at EJAF proves brands can do more than raise awareness —they can dismantle stigma and drive ...
A recent survey conducted by the HIV Medicine Association identified barriers to implementation of long-acting injectables ...
Cuts to HIV/AIDS funding could threaten the 40 years of work that has gone into ending the AIDS epidemic — potentially ...
A surge in the number of new HIV cases has been reported in the Swan Valley region, prompting Manitoba health officials to ...